101 related articles for article (PubMed ID: 14679962)
1. Breast-cancer drug letrozole picks up where tamoxifen leaves off. But we don't know who stands to benefit the most from this follow-up approach.
Runowicz CD
Health News; 2003 Dec; 9(12):4-5. PubMed ID: 14679962
[No Abstract] [Full Text] [Related]
2. Alternative to tamoxifen effective for preventing breast cancer recurrence.
Mayo Clin Womens Healthsource; 2005 May; 9(5):3. PubMed ID: 15891689
[No Abstract] [Full Text] [Related]
3. New breast cancer drug.
Brink S
US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
[No Abstract] [Full Text] [Related]
4. Prescribing extended adjuvant letrozole.
Gelmon K
Breast; 2007 Oct; 16(5):446-55. PubMed ID: 17544670
[TBL] [Abstract][Full Text] [Related]
5. Resumption of menses with initiation of letrozole after five years of amenorrhea on tamoxifen: caution needed when using tamoxifen followed by aromatase inhibitors.
Hargis JB; Nakajima ST
Cancer Invest; 2006 Mar; 24(2):174-7. PubMed ID: 16537187
[TBL] [Abstract][Full Text] [Related]
6. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial.
Forbes JF
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S2-7. PubMed ID: 16730270
[TBL] [Abstract][Full Text] [Related]
7. New treatment boosts outlook for breast cancer survivors.
Mayo Clin Womens Healthsource; 2004 Mar; 8(3):3. PubMed ID: 15001847
[No Abstract] [Full Text] [Related]
8. The Letrozole Breast Cancer Trial: clinical implications and remaining questions.
Chen WY; Manson JE
Womens Health Issues; 2004; 14(1):7-10. PubMed ID: 15001182
[No Abstract] [Full Text] [Related]
9. Letrozole in breast cancer.
Harris SR
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971059
[No Abstract] [Full Text] [Related]
10. Drugs may improve long-term outcomes after breast cancer.
Mayo Clin Health Lett; 2004 Mar; 22(3):4. PubMed ID: 15000065
[No Abstract] [Full Text] [Related]
11. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
Goss PE
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
[TBL] [Abstract][Full Text] [Related]
12. Focus on anastrozole and breast cancer.
Mokbel K
Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
[TBL] [Abstract][Full Text] [Related]
13. Letrozole in breast cancer.
Hietanen P; Mäkelä M
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971057
[No Abstract] [Full Text] [Related]
14. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen.
Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R
Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902
[TBL] [Abstract][Full Text] [Related]
15. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
Kaufmann M; Rody A
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
[TBL] [Abstract][Full Text] [Related]
16. Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.
Twombly R
J Natl Cancer Inst; 2003 Dec; 95(23):1738-9. PubMed ID: 14652229
[No Abstract] [Full Text] [Related]
17. Anastrozole called breast cancer "lifesaver". Recipients showed a 40 percent decrease in relapse risk when switched to anastrazole after tamoxifen.
Health News; 2005 Dec; 11(12):13-4. PubMed ID: 16416553
[No Abstract] [Full Text] [Related]
18. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
Tuma RS
J Natl Cancer Inst; 2006 Jan; 98(2):86-7. PubMed ID: 16418506
[No Abstract] [Full Text] [Related]
19. Benefit of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.
DeGrendele H
Clin Breast Cancer; 2003 Dec; 4(5):311-2. PubMed ID: 14715105
[No Abstract] [Full Text] [Related]
20. [Interview with Prof. Dr. Wolfgang Eiermann. Which women need a medicamentous breast cancer prophylaxis?].
Eiermann W
MMW Fortschr Med; 2003 Dec; 145(50):8. PubMed ID: 14963963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
